Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

MRI-based prediction of molecular subgrouping in medulloblastoma: images speak louder than words.

Dasgupta A, Gupta T.

Oncotarget. 2019 Aug 6;10(47):4805-4807. doi: 10.18632/oncotarget.27097. eCollection 2019 Aug 6. No abstract available.

2.

Nomograms based on preoperative multiparametric magnetic resonance imaging for prediction of molecular subgrouping in medulloblastoma: results from a radiogenomics study of 111 patients.

Dasgupta A, Gupta T, Pungavkar S, Shirsat N, Epari S, Chinnaswamy G, Mahajan A, Janu A, Moiyadi A, Kannan S, Krishnatry R, Sastri GJ, Jalali R.

Neuro Oncol. 2019 Jan 1;21(1):115-124. doi: 10.1093/neuonc/noy093.

PMID:
29846693
3.

MRI features as a helpful tool to predict the molecular subgroups of medulloblastoma: state of the art.

Colafati GS, Voicu IP, Carducci C, Miele E, Carai A, Di Loreto S, Marrazzo A, Cacchione A, Cecinati V, Tornesello A, Mastronuzzi A.

Ther Adv Neurol Disord. 2018 Jun 18;11:1756286418775375. doi: 10.1177/1756286418775375. eCollection 2018. Review.

4.

[Effect of long noncoding RNA SPRY4-IT1 on proliferation and metastasis of medulloblastoma].

Shi PF, Ji HL, Luo YK, Mao TM, Chen X, Zhou KY.

Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2017 Jan 8;33(1):78-82. doi: 10.12047/j.cjap.5448.2017.020. Chinese.

PMID:
29926610
6.

[Molecular subgrouping and characterization analysis of medulloblastomas in a cohort of Japanese patients].

Wataya T, Hamasaki M, Taylor MD.

No Shinkei Geka. 2015 Feb;43(2):117-25. doi: 10.11477/mf.1436202965. Japanese.

PMID:
25672552
7.

Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma.

Leal LF, Evangelista AF, de Paula FE, Caravina Almeida G, Carloni AC, Saggioro F, Stavale JN, Malheiros SMF, Mançano B, de Oliveira MA, Luu B, Neder L, Taylor MD, Reis RM.

Neuropathology. 2018 Oct;38(5):475-483. doi: 10.1111/neup.12508. Epub 2018 Aug 28.

PMID:
30155928
8.

Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping.

Gupta T, Maitre M, Sastri GJ, Krishnatry R, Shirsat N, Epari S, Sahay A, Chinnaswamy G, Patil V, Shetty P, Moiyadi A.

J Neurooncol. 2019 Sep;144(2):283-291. doi: 10.1007/s11060-019-03225-9. Epub 2019 Jun 24.

PMID:
31236820
9.

Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres.

Kaur K, Jha P, Pathak P, Suri V, Sharma MC, Garg A, Suri A, Sarkar C.

J Neurooncol. 2019 Jul;143(3):393-403. doi: 10.1007/s11060-019-03187-y. Epub 2019 May 18.

PMID:
31104222
10.

Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort.

Pietsch T, Schmidt R, Remke M, Korshunov A, Hovestadt V, Jones DT, Felsberg J, Kaulich K, Goschzik T, Kool M, Northcott PA, von Hoff K, von Bueren AO, Friedrich C, Mynarek M, Skladny H, Fleischhack G, Taylor MD, Cremer F, Lichter P, Faldum A, Reifenberger G, Rutkowski S, Pfister SM.

Acta Neuropathol. 2014 Jul;128(1):137-49. doi: 10.1007/s00401-014-1276-0. Epub 2014 May 4.

11.

Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice.

Gupta T, Shirsat N, Jalali R.

Curr Pediatr Rev. 2015;11(2):106-19. Review.

PMID:
26133181
12.

Clustering of self-organizing map identifies five distinct medulloblastoma subgroups.

Cao C, Wang W, Jiang P.

Cancer Biomark. 2016;16(3):327-32. doi: 10.3233/CBM-160570.

PMID:
26889815
13.

Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays.

Hovestadt V, Remke M, Kool M, Pietsch T, Northcott PA, Fischer R, Cavalli FM, Ramaswamy V, Zapatka M, Reifenberger G, Rutkowski S, Schick M, Bewerunge-Hudler M, Korshunov A, Lichter P, Taylor MD, Pfister SM, Jones DT.

Acta Neuropathol. 2013 Jun;125(6):913-6. doi: 10.1007/s00401-013-1126-5. Epub 2013 May 14. No abstract available.

14.

The clinical experience of medulloblastoma treatment and the significance of time sequence for development of leptomeningeal metastasis.

Hsieh PC, Wu CT, Lin KL, Jaing TH, Tseng CK, Lui TN, Jung SM.

Childs Nerv Syst. 2008 Dec;24(12):1463-7. doi: 10.1007/s00381-008-0697-2. Epub 2008 Sep 19.

PMID:
18802711
15.

Facts speak louder than words.

Chen SL.

Catheter Cardiovasc Interv. 2016 Mar;87 Suppl 1:552-3. doi: 10.1002/ccd.26469. No abstract available.

PMID:
26995166
16.

Languages: land may speak louder than words.

Stocker M.

Nature. 2005 Dec 15;438(7070):914. No abstract available.

PMID:
16355189
17.

Case-based review: pediatric medulloblastoma.

Kline CN, Packer RJ, Hwang EI, Raleigh DR, Braunstein S, Raffel C, Bandopadhayay P, Solomon DA, Aboian M, Cha S, Mueller S.

Neurooncol Pract. 2017 Sep;4(3):138-150. doi: 10.1093/nop/npx011. Epub 2017 Aug 11. Review.

18.

MRS for non-invasive medulloblastoma subgrouping.

Bagcchi S.

Lancet Oncol. 2015 Sep;16(9):e433. doi: 10.1016/S1470-2045(15)00225-9. Epub 2015 Aug 13. No abstract available.

PMID:
26278159
19.

What's in a Name? Actions Speak Louder Than Words.

Meyer RA.

J Oral Maxillofac Surg. 2017 May;75(5):884. doi: 10.1016/j.joms.2017.01.028. Epub 2017 Feb 24. No abstract available.

PMID:
28238821
20.

When actions speak louder than words.

Jenkins LB.

RN. 1986 Jul;49(7):42-4. No abstract available.

PMID:
3637001

Supplemental Content

Support Center